<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9"><gtr:id>3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9</gtr:id><gtr:name>University of Oxford</gtr:name><gtr:address><gtr:line1>University Chest</gtr:line1><gtr:line2>Wellington Square</gtr:line2><gtr:line4>Oxford</gtr:line4><gtr:postCode>OX1 2JD</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/78778E97-5A2E-40A6-A88F-137A343A3530"><gtr:id>78778E97-5A2E-40A6-A88F-137A343A3530</gtr:id><gtr:name>University of Toronto</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/E5FC54EE-85F6-4EB6-90F1-0E71B0B23CAE"><gtr:id>E5FC54EE-85F6-4EB6-90F1-0E71B0B23CAE</gtr:id><gtr:name>University of Kelaniya</gtr:name><gtr:address><gtr:line1>Dalugama</gtr:line1><gtr:region>Outside UK</gtr:region></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9"><gtr:id>3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9</gtr:id><gtr:name>University of Oxford</gtr:name><gtr:address><gtr:line1>University Chest</gtr:line1><gtr:line2>Wellington Square</gtr:line2><gtr:line4>Oxford</gtr:line4><gtr:postCode>OX1 2JD</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9"><gtr:id>3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9</gtr:id><gtr:name>University of Oxford</gtr:name><gtr:address><gtr:line1>University Chest</gtr:line1><gtr:line2>Wellington Square</gtr:line2><gtr:line4>Oxford</gtr:line4><gtr:postCode>OX1 2JD</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/78778E97-5A2E-40A6-A88F-137A343A3530"><gtr:id>78778E97-5A2E-40A6-A88F-137A343A3530</gtr:id><gtr:name>University of Toronto</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/E5FC54EE-85F6-4EB6-90F1-0E71B0B23CAE"><gtr:id>E5FC54EE-85F6-4EB6-90F1-0E71B0B23CAE</gtr:id><gtr:name>University of Kelaniya</gtr:name><gtr:address><gtr:line1>Dalugama</gtr:line1><gtr:region>Outside UK</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/D3AAB31B-2B14-433F-A8F7-C5574660FBA7"><gtr:id>D3AAB31B-2B14-433F-A8F7-C5574660FBA7</gtr:id><gtr:firstName>David</gtr:firstName><gtr:surname>Weatherall</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=MC_UU_12009%2F13"><gtr:id>2C4E1779-F6AA-45F8-829A-0B8AD3BAAA59</gtr:id><gtr:title>Global Study of Thalassaemia</gtr:title><gtr:status>Active</gtr:status><gtr:grantCategory>Intramural</gtr:grantCategory><gtr:grantReference>MC_UU_12009/13</gtr:grantReference><gtr:abstractText>The inherited disorders of haemoglobin are by far the commonest genetic diseases and will cause an increasing global health problem in the future. This programme is directed at trying to develop better ways of estimating the true global burden of these diseases, and, in particular, better to understand the reasons for why some of them are so remarkably diverse despite being due to the same genetic defect. A better understanding of these mechanisms are absolutely critical to improving the future management of many of these diseases in the developing countries.</gtr:abstractText><gtr:technicalSummary>The inherited disorders of haemoglobin are by far the commonest monogenic diseases. Over 300,000 babies are born each year with either sickle cell anaemia or a form of thalassaemia; 80% of these births occur in low or middle-income countries. The commonest forms of severe thalassaemia are the ? thalassaemias, which are divided into ? thalassaemia major and the co-inheritance of ? thalassaemia and haemoglobin (Hb) E, HbE ? thalassaemia. Globally, HbE ? thalassaemia comprises about 50% of severe cases of ? thalassaemia and occurs at its highest incidence in parts of India, Bangladesh and throughout Southeast Asia. The management of HbE ? thalassaemia is in many ways more difficult than that of other severe forms of ? thalassaemia because it has such an extraordinarily diverse clinical phenotype, ranging from a transfusion-dependent disorder similar to ? thalassaemia major to a condition which is compatible with survival into adult life with little or no transfusion. As well as this phenotypic diversity the management of HbE ? thalassaemia is further complicated by the instability of its clinical manifestations over the first few years of life. Another difficult aspect of the phenotype associated with its clinical management is the fact 
that the steady-state haemoglobin levels in the mild and severe phenotypes often only vary between 1-2 g/dl. Surprisingly however, there are very few data on the natural history of this disease and its overall mortality, either in the developed or developing countries. 
Over the last 15 years we have developed partnerships with a variety of countries in Asia, notably Sri Lanka, to study HbE ? thalassaemia. This work has two major objectives. First, to try to understand some of the reasons for the remarkable phenotypic variability of the disease. Second, to describe its natural history and, in particular, to follow the course of older patients with this condition who have not received regular transfusion to determine whether a lifelong course of a low haemoglobin level is associated with complications as these patients age. By raising money from several different sources it has been possible to build a new treatment centre for these patients in Kurunegala, Sri Lanka, which now cares for over 600 patients with ? thalassaemia, 200 of which have HbE ? thalassaemia. We have also raised money for the building of a major diagnostic centre at the University of Kelaniya in Colombo, to which is attached an adult thalassaemia centre and full facilities for diagnosis at the protein and DNA level.

The third aspect of this programme is directed at micromapping the frequency of the thalassaemias in Asian countries. Little work has been done on the population frequency of these diseases since the 1980s and there are very limited data, a major deficiency in trying to determine their true public health problems. Most of the published data is based on one or two centres and it is already clear that the distribution of the thalassaemias is extremely heterogeneous within different countries. Therefore extensive mapping of their frequency is required from numerous different regions in high-frequency populations. Towards this end we have carried out several micromapping studies and are also trying to develop an Asian Network between countries which have already developed this type of technology and those where facilities for the diagnosis and management of the thalassaemias are non-existent.</gtr:technicalSummary><gtr:fund><gtr:end>2022-03-31</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2012-04-01</gtr:start><gtr:type>EXPENDITURE_ACTUAL</gtr:type><gtr:valuePounds>135000</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Kelaniya</gtr:collaboratingOrganisation><gtr:country>Sri Lanka, Democratic Socialist Republic of</gtr:country><gtr:description>Long-term collaborative programme with Department of Medicine, University of Kelaniya, Sri Lanka</gtr:description><gtr:id>DF402B57-4742-41A7-8A10-84D19CBA1D1D</gtr:id><gtr:impact>Capacity building (new treatment and diagnostic centre built in Sri Lanka) and many publications - 22631040, 21879898, 21726207, 20712787, 22885163, 23138098, 23834321,25519750, 25572187</gtr:impact><gtr:outcomeId>5455dad58d1754.34178745-1</gtr:outcomeId><gtr:partnerContribution>We have trained Professor Premawardhena and his staff in the diagnosis and care of the thalassaemias and helped them develop some local research programmes. We have also carried out a lot of capacity building - having built them a new treatment centre and diagnostic centre and helped the government to develop a thalassaemia control programme. Our partners have taken part in every aspect of this programme over the last 15 years</gtr:partnerContribution><gtr:piContribution>This programme has been going on for 15 years and has entailed us carrying out wide range research on the different forms of thalassaemia in Sri Lanka</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Oxford</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Research partnership with the Department of Evolutionary Ecology of Infectious Diseases</gtr:description><gtr:id>31F0F5B5-D44E-4C73-B43E-AB0A844F59ED</gtr:id><gtr:impact>Many publications - 24748392, 23874164, 23591685, 23568771, 23103089, 21045822, 23874164, 24748392, 25521998</gtr:impact><gtr:outcomeId>5455d9d29a28f0.00190880-1</gtr:outcomeId><gtr:partnerContribution>The essential statistical analyses of every aspect of our thalassaemia work</gtr:partnerContribution><gtr:piContribution>My team carries out all the diagnostic and molecular analysis together with the population genetics of the inherited haemoglobin disorders while Professor Gupta's group provide invaluable aid with the statistical analysis of every aspect of our work.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Toronto</gtr:collaboratingOrganisation><gtr:country>Canada</gtr:country><gtr:description>Long term collaboration with the Hemoglobal Program in Toronto</gtr:description><gtr:id>A8A36B35-4148-4C6B-BCCD-79B9B6309B6D</gtr:id><gtr:impact>Capacity building (new treatment and diagnostic centre built in Sri Lanka) and many publications - 22631040, 21879898, 21726207, 20712787, 22885163, 23138098, 23834321, 25519750, 25572187</gtr:impact><gtr:outcomeId>5455dc4d4a7a77.08806021-1</gtr:outcomeId><gtr:partnerContribution>They have played a particularly strong role in the analysis of the clinical features of thalassaemia in Sri Lanka and also parts of India where we also work</gtr:partnerContribution><gtr:piContribution>The Toronto group have taken part in our collaboration with Sri Lanka and helped it to develop in every level</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs/><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>50000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Management of inherited blood diseases in Sri Lanka</gtr:description><gtr:end>2016-12-02</gtr:end><gtr:fundingOrg>The Wolfson Foundation</gtr:fundingOrg><gtr:id>320D381A-D0A7-43C8-B81F-09CED332576B</gtr:id><gtr:outcomeId>58b955ab5ed4c1.70467350</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2015-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>94854</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Research support from The Wellcome Trust at regular intervals since retirement.</gtr:description><gtr:end>2015-09-02</gtr:end><gtr:fundingOrg>Wellcome Trust</gtr:fundingOrg><gtr:fundingRef>053267/Z/98/G</gtr:fundingRef><gtr:id>FDC90052-54A3-4BED-8576-07B10BBDDD6D</gtr:id><gtr:outcomeId>5455d7914ef159.39002073</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2013-09-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>112750</gtr:amountPounds><gtr:country>United States of America</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Anthony Cerami and Ann Dunne Foundation for World Health</gtr:description><gtr:end>2019-02-02</gtr:end><gtr:fundingOrg>Anthony Cerami and Anne Dunne Foundation for World Health</gtr:fundingOrg><gtr:id>4C920C0C-19C1-4A9D-9866-A6463E5C785C</gtr:id><gtr:outcomeId>58b85858778915.36676018</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2017-03-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>100000</gtr:amountPounds><gtr:country>United States of America</gtr:country><gtr:currCode>USD</gtr:currCode><gtr:currCountryCode>Ecuador</gtr:currCountryCode><gtr:currLang>es_EC</gtr:currLang><gtr:description>Gift from American Charity</gtr:description><gtr:end>2020-01-02</gtr:end><gtr:fundingOrg>Anthony Cerami and Anne Dunne Foundation for World Health</gtr:fundingOrg><gtr:id>5E31B579-5785-4051-92B4-8FAEDC3FCB08</gtr:id><gtr:outcomeId>5455d826e246c2.53258137</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>E6C0C29E-1598-4BA8-B22C-6EFB37324547</gtr:id><gtr:title>Methemoglobinemia and ascorbate deficiency in hemoglobin E ? thalassemia: metabolic and clinical implications.</gtr:title><gtr:parentPublicationTitle>Blood</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1eb2e67abed96f3316813116ebac34af"><gtr:id>1eb2e67abed96f3316813116ebac34af</gtr:id><gtr:otherNames>Allen A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0006-4971</gtr:issn><gtr:outcomeId>5452008f70cca2.10495699</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E7FF4752-A421-4650-A0ED-6A0560B78925</gtr:id><gtr:title>Progress Toward the Control and Management of the Thalassemias.</gtr:title><gtr:parentPublicationTitle>Hematology/oncology clinics of North America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/56d8d1202dd9d78a470535dc57b2d16f"><gtr:id>56d8d1202dd9d78a470535dc57b2d16f</gtr:id><gtr:otherNames>Fucharoen S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0889-8588</gtr:issn><gtr:outcomeId>58b954e04e3800.96933798</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>10356EB7-D732-4204-BE10-D1AF7FADFABD</gtr:id><gtr:title>Haemoglobin variants, iron status and anaemia in Sri Lankan adolescents with low red cell indices: A cross sectional survey.</gtr:title><gtr:parentPublicationTitle>Blood cells, molecules &amp; diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5f614cbbe3bb05b7efcb97481e49848b"><gtr:id>5f614cbbe3bb05b7efcb97481e49848b</gtr:id><gtr:otherNames>Rodrigo R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2018-01-01</gtr:date><gtr:issn>1079-9796</gtr:issn><gtr:outcomeId>5a99370b674ee7.06842338</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>174B1839-67A0-4867-8673-F49EB0E0ACCD</gtr:id><gtr:title>The role of the inherited disorders of hemoglobin, the first &amp;quot;molecular diseases,&amp;quot; in the future of human genetics.</gtr:title><gtr:parentPublicationTitle>Annual review of genomics and human genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/addf065b4b0c5b9f18e809e8fbf949c8"><gtr:id>addf065b4b0c5b9f18e809e8fbf949c8</gtr:id><gtr:otherNames>Weatherall DJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1527-8204</gtr:issn><gtr:outcomeId>544e33661993c3.68933615</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>EB27DBDC-6E22-4962-A8E0-29386D64EFF7</gtr:id><gtr:title>The a-thalassemias.</gtr:title><gtr:parentPublicationTitle>The New England journal of medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2fb11f00161c094a401c24f80031ca77"><gtr:id>2fb11f00161c094a401c24f80031ca77</gtr:id><gtr:otherNames>Piel FB</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0028-4793</gtr:issn><gtr:outcomeId>56d02f62ae5f81.74745171</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>13134AF9-94C9-444C-87ED-120BEAE1BEE0</gtr:id><gtr:title>Hepcidin detects iron deficiency in Sri Lankan adolescents with a high burden of hemoglobinopathy: A diagnostic test accuracy study.</gtr:title><gtr:parentPublicationTitle>American journal of hematology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/dc040afaff8b8a43566158217d4cb069"><gtr:id>dc040afaff8b8a43566158217d4cb069</gtr:id><gtr:otherNames>Wray K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0361-8609</gtr:issn><gtr:outcomeId>58b954e00189d7.29807683</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C22EDE5C-F965-42E8-AD64-1BD470F530BF</gtr:id><gtr:title>Alpha thalassaemia and extended alpha globin genes in Sri Lanka.</gtr:title><gtr:parentPublicationTitle>Blood cells, molecules &amp; diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7bbc5863c7d7dad1d6b6259abab93110"><gtr:id>7bbc5863c7d7dad1d6b6259abab93110</gtr:id><gtr:otherNames>Suresh S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1079-9796</gtr:issn><gtr:outcomeId>544e3366b75309.92889362</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9DC1D481-6D77-4143-8205-27C46841A961</gtr:id><gtr:title>Thalassaemia.</gtr:title><gtr:parentPublicationTitle>Lancet (London, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f45314e73d684d229d11a8af9068949f"><gtr:id>f45314e73d684d229d11a8af9068949f</gtr:id><gtr:otherNames>Taher AT</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2018-01-01</gtr:date><gtr:issn>0140-6736</gtr:issn><gtr:outcomeId>5a99370bbd26c7.12687098</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>57ED63A9-0277-4F5E-ADBF-2A8F56181280</gtr:id><gtr:title>Global Hematology.</gtr:title><gtr:parentPublicationTitle>Hematology/oncology clinics of North America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/371c70d042093621dd36ec81affc829e"><gtr:id>371c70d042093621dd36ec81affc829e</gtr:id><gtr:otherNames>Roberts DJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0889-8588</gtr:issn><gtr:outcomeId>58b954e02c0843.30227568</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>617268A1-90A1-4790-9561-27190BA85A22</gtr:id><gtr:title>The definition and epidemiology of non-transfusion-dependent thalassemia.</gtr:title><gtr:parentPublicationTitle>Blood reviews</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/addf065b4b0c5b9f18e809e8fbf949c8"><gtr:id>addf065b4b0c5b9f18e809e8fbf949c8</gtr:id><gtr:otherNames>Weatherall DJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0268-960X</gtr:issn><gtr:outcomeId>5452008f99b118.86978132</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D26B0F4E-CBE2-4B1E-8E6D-F701964240AE</gtr:id><gtr:title>Epistasis and the sensitivity of phenotypic screens for beta thalassaemia.</gtr:title><gtr:parentPublicationTitle>British journal of haematology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e9cea30f8012bfe4c1a52e03ada27fe2"><gtr:id>e9cea30f8012bfe4c1a52e03ada27fe2</gtr:id><gtr:otherNames>Penman BS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0007-1048</gtr:issn><gtr:outcomeId>56d02f62486ea7.13332898</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>05DB3E18-CEED-4F2E-BDFD-A07D58A29247</gtr:id><gtr:title>The hemoglobin E thalassemias.</gtr:title><gtr:parentPublicationTitle>Cold Spring Harbor perspectives in medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/56d8d1202dd9d78a470535dc57b2d16f"><gtr:id>56d8d1202dd9d78a470535dc57b2d16f</gtr:id><gtr:otherNames>Fucharoen S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>2157-1422</gtr:issn><gtr:outcomeId>5452008f40d734.52306696</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>07F16D65-B1AC-402F-BD1A-1359DDC4D768</gtr:id><gtr:title>Commentary on &amp;quot;The modifying effect of Xmn1-HBG2 on thalassemic phenotype is associated with its linked elements in the beta globin locus control region, including the palindromic site at 5' HS4&amp;quot; by M. Neishabury et al.</gtr:title><gtr:parentPublicationTitle>Blood cells, molecules &amp; diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/addf065b4b0c5b9f18e809e8fbf949c8"><gtr:id>addf065b4b0c5b9f18e809e8fbf949c8</gtr:id><gtr:otherNames>Weatherall DJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1079-9796</gtr:issn><gtr:outcomeId>545200901bdea3.77257762</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>ADA75DEA-30A1-48B3-A3C0-5298B534F986</gtr:id><gtr:title>Iron status and anaemia in Sri Lankan secondary school children: A cross-sectional survey.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1eb2e67abed96f3316813116ebac34af"><gtr:id>1eb2e67abed96f3316813116ebac34af</gtr:id><gtr:otherNames>Allen A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>5a99370b8b10c2.20847492</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C4F370E3-DF54-4A61-A4EB-8FA8B0057169</gtr:id><gtr:title>Online biomedical resources for malaria-related red cell disorders.</gtr:title><gtr:parentPublicationTitle>Human mutation</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2fb11f00161c094a401c24f80031ca77"><gtr:id>2fb11f00161c094a401c24f80031ca77</gtr:id><gtr:otherNames>Piel FB</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1059-7794</gtr:issn><gtr:outcomeId>544e33668dbd22.56667841</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8136E7AC-8227-45BE-9976-5EB42CE4C354</gtr:id><gtr:title>A journey in science: early lessons from the hemoglobin field.</gtr:title><gtr:parentPublicationTitle>Molecular medicine (Cambridge, Mass.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/addf065b4b0c5b9f18e809e8fbf949c8"><gtr:id>addf065b4b0c5b9f18e809e8fbf949c8</gtr:id><gtr:otherNames>Weatherall DJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1076-1551</gtr:issn><gtr:outcomeId>56d02f61e38601.96165897</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5F9F7B21-85CE-4150-890D-650BC7B9CF4A</gtr:id><gtr:title>A systematic analysis of global anemia burden from 1990 to 2010.</gtr:title><gtr:parentPublicationTitle>Blood</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6ecac8939e47d735242b710466146e03"><gtr:id>6ecac8939e47d735242b710466146e03</gtr:id><gtr:otherNames>Kassebaum NJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0006-4971</gtr:issn><gtr:outcomeId>56d02fc05c6a14.48666480</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9B3E6E92-A12F-41C8-A67D-5DEE0AE4477F</gtr:id><gtr:title>Global migration and the changing distribution of sickle haemoglobin: a quantitative study of temporal trends between 1960 and 2000.</gtr:title><gtr:parentPublicationTitle>The Lancet. Global health</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2fb11f00161c094a401c24f80031ca77"><gtr:id>2fb11f00161c094a401c24f80031ca77</gtr:id><gtr:otherNames>Piel FB</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>2214-109X</gtr:issn><gtr:outcomeId>544e3365ad9a19.62423029</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B248CB5F-86FA-43EF-B6F6-D4975C75A765</gtr:id><gtr:title>World distribution, population genetics, and health burden of the hemoglobinopathies.</gtr:title><gtr:parentPublicationTitle>Cold Spring Harbor perspectives in medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5a1db8361b9eebcde6c7688f98e889f6"><gtr:id>5a1db8361b9eebcde6c7688f98e889f6</gtr:id><gtr:otherNames>Williams TN</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>2157-1422</gtr:issn><gtr:outcomeId>5452008f18a224.10955096</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>02E08361-C99E-4A0E-BF4A-19B7E753B3D2</gtr:id><gtr:title>The evolutionary and clinical implications of the uneven distribution of the frequency of the inherited haemoglobin variants over short geographical distances.</gtr:title><gtr:parentPublicationTitle>British journal of haematology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4da9850fa6487a99e77779f7a102d0c8"><gtr:id>4da9850fa6487a99e77779f7a102d0c8</gtr:id><gtr:otherNames>Premawardhena A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0007-1048</gtr:issn><gtr:outcomeId>58b954dfcc6c63.42101878</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0FDA853D-8885-49C0-8816-9C466C54601F</gtr:id><gtr:title>Hepcidin is suppressed by erythropoiesis in hemoglobin E ?-thalassemia and ?-thalassemia trait.</gtr:title><gtr:parentPublicationTitle>Blood</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7e050bd6475c7c807ec5722cb9a2cc56"><gtr:id>7e050bd6475c7c807ec5722cb9a2cc56</gtr:id><gtr:otherNames>Jones E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0006-4971</gtr:issn><gtr:outcomeId>56d02f627f1e48.63714776</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>30F12836-0A27-42D1-BF9D-9ED6DB112699</gtr:id><gtr:title>Is medical research in danger of suffering the same fate as the NHS?</gtr:title><gtr:parentPublicationTitle>QJM : monthly journal of the Association of Physicians</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/addf065b4b0c5b9f18e809e8fbf949c8"><gtr:id>addf065b4b0c5b9f18e809e8fbf949c8</gtr:id><gtr:otherNames>Weatherall DJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1460-2393</gtr:issn><gtr:outcomeId>56d02f62dc6355.33751662</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CE30AA36-0D06-42C8-BF1F-FD569CA9A1C4</gtr:id><gtr:title>Global epidemiology of sickle haemoglobin in neonates: a contemporary geostatistical model-based map and population estimates.</gtr:title><gtr:parentPublicationTitle>Lancet (London, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2fb11f00161c094a401c24f80031ca77"><gtr:id>2fb11f00161c094a401c24f80031ca77</gtr:id><gtr:otherNames>Piel FB</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0140-6736</gtr:issn><gtr:outcomeId>544e3366e78df1.53591757</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6C9854B4-9EB4-4B9B-A20C-1583E43C1309</gtr:id><gtr:title>Rare hemoglobin variants: Hb G-Szuhu (HBB: c.243C&amp;gt;G), Hb G-Coushatta (HBB: c.68A&amp;gt;C) and Hb Mizuho (HBB: c.206T&amp;gt;C) in Sri Lankan families.</gtr:title><gtr:parentPublicationTitle>Hemoglobin</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8e20cc9811fbdd81274d4b04d3a529dc"><gtr:id>8e20cc9811fbdd81274d4b04d3a529dc</gtr:id><gtr:otherNames>Perera PS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0363-0269</gtr:issn><gtr:outcomeId>56d02f61ba82a2.94592395</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A27E0656-E703-44B9-AD05-FDC6476303B0</gtr:id><gtr:title>Introduction: The Complexity and Challenge of Preventing, Treating, and Managing Blood Diseases in the Developing Countries.</gtr:title><gtr:parentPublicationTitle>Hematology/oncology clinics of North America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/371c70d042093621dd36ec81affc829e"><gtr:id>371c70d042093621dd36ec81affc829e</gtr:id><gtr:otherNames>Roberts DJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0889-8588</gtr:issn><gtr:outcomeId>58b954e079f5d8.17957468</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>AE62FA8E-3383-41B9-8045-8E6CE70A5309</gtr:id><gtr:title>The distribution of haemoglobin C and its prevalence in newborns in Africa.</gtr:title><gtr:parentPublicationTitle>Scientific reports</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2fb11f00161c094a401c24f80031ca77"><gtr:id>2fb11f00161c094a401c24f80031ca77</gtr:id><gtr:otherNames>Piel FB</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>2045-2322</gtr:issn><gtr:outcomeId>544e3366579183.02713950</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8660A047-2E25-44D2-BC7D-2FF2D2CF3160</gtr:id><gtr:title>Sickle-cell disease: a call to action.</gtr:title><gtr:parentPublicationTitle>Transactions of the Royal Society of Tropical Medicine and Hygiene</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2fb11f00161c094a401c24f80031ca77"><gtr:id>2fb11f00161c094a401c24f80031ca77</gtr:id><gtr:otherNames>Piel FB</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0035-9203</gtr:issn><gtr:outcomeId>56d02f6191b7c6.16675683</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A932324C-8933-4669-802E-7E0DEF51C434</gtr:id><gtr:title>The Evolving Spectrum of the Epidemiology of Thalassemia.</gtr:title><gtr:parentPublicationTitle>Hematology/oncology clinics of North America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/addf065b4b0c5b9f18e809e8fbf949c8"><gtr:id>addf065b4b0c5b9f18e809e8fbf949c8</gtr:id><gtr:otherNames>Weatherall DJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2018-01-01</gtr:date><gtr:issn>0889-8588</gtr:issn><gtr:outcomeId>5a99370b333be6.95973157</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>58F9F887-416C-4394-B3D2-A5A01B83F024</gtr:id><gtr:title>The future of academic haematology.</gtr:title><gtr:parentPublicationTitle>British journal of haematology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f4372a7f2d5ea1d6313b49e5c539a538"><gtr:id>f4372a7f2d5ea1d6313b49e5c539a538</gtr:id><gtr:otherNames>Hay D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0007-1048</gtr:issn><gtr:outcomeId>58b954df8ec8a1.27736525</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D4D83FC4-184C-4C60-8D1A-818732AFFA98</gtr:id><gtr:title>Global burden of sickle cell anaemia in children under five, 2010-2050: modelling based on demographics, excess mortality, and interventions.</gtr:title><gtr:parentPublicationTitle>PLoS medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2fb11f00161c094a401c24f80031ca77"><gtr:id>2fb11f00161c094a401c24f80031ca77</gtr:id><gtr:otherNames>Piel FB</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1549-1277</gtr:issn><gtr:outcomeId>544e3365db4857.33223921</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">MC_UU_12009/13</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>939798CA-B6AE-4C12-9DCC-A0F88F84E6F3</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Blood</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>9A8BEDCC-D902-4C9A-8CCF-C974265EA3FB</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>2.4  Surveillance and distribution</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>